Inozyme Pharma Inc (INZY)
2.81
+0.12
(+4.46%)
USD |
NASDAQ |
Nov 22, 16:00
2.82
+0.01
(+0.36%)
After-Hours: 20:00
Inozyme Pharma Price to Book Value: 2.180 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 2.180 |
| November 21, 2024 | 2.087 |
| November 20, 2024 | 2.165 |
| November 19, 2024 | 2.180 |
| November 18, 2024 | 2.235 |
| November 15, 2024 | 2.425 |
| November 14, 2024 | 2.662 |
| November 13, 2024 | 2.755 |
| November 12, 2024 | 2.918 |
| November 11, 2024 | 3.104 |
| November 08, 2024 | 3.119 |
| November 07, 2024 | 3.181 |
| November 06, 2024 | 3.282 |
| November 05, 2024 | 3.158 |
| November 04, 2024 | 3.430 |
| November 01, 2024 | 3.383 |
| October 31, 2024 | 3.329 |
| October 30, 2024 | 3.523 |
| October 29, 2024 | 3.585 |
| October 28, 2024 | 3.706 |
| October 25, 2024 | 3.713 |
| October 24, 2024 | 3.806 |
| October 23, 2024 | 3.799 |
| October 22, 2024 | 3.961 |
| October 21, 2024 | 4.093 |
| Date | Value |
|---|---|
| October 18, 2024 | 4.295 |
| October 17, 2024 | 3.992 |
| October 16, 2024 | 4.116 |
| October 15, 2024 | 4.163 |
| October 14, 2024 | 4.070 |
| October 11, 2024 | 4.016 |
| October 10, 2024 | 3.822 |
| October 09, 2024 | 3.961 |
| October 08, 2024 | 4.070 |
| October 07, 2024 | 4.047 |
| October 04, 2024 | 4.008 |
| October 03, 2024 | 3.923 |
| October 02, 2024 | 3.899 |
| October 01, 2024 | 3.892 |
| September 30, 2024 | 4.054 |
| September 27, 2024 | 3.681 |
| September 26, 2024 | 3.653 |
| September 25, 2024 | 3.660 |
| September 24, 2024 | 3.717 |
| September 23, 2024 | 3.731 |
| September 20, 2024 | 4.072 |
| September 19, 2024 | 4.108 |
| September 18, 2024 | 4.129 |
| September 17, 2024 | 4.143 |
| September 16, 2024 | 4.257 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3147
Minimum
Dec 30 2022
4.295
Maximum
Oct 18 2024
2.185
Average
2.374
Median
May 23 2024
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.324 |
| AIM ImmunoTech Inc | 4.596 |
| IGC Pharma Inc | 3.738 |
| NovaBay Pharmaceuticals Inc | 3.121 |
| Protalix BioTherapeutics Inc | 3.836 |
Price to Book Value Related Metrics
| Price | 2.81 |
| Earnings Yield | -55.52% |
| Market Cap | 180.52M |